Patents Assigned to Behavioral Diagnostics, LLC
  • METHODS AND COMPOSITIONS FOR SMOKING CESSATION
    Publication number: 20230041334
    Abstract: This disclosure describes the use of a phosphodiesterase-5 (PDE5) inhibitor to reduce an individual's desire to smoke and/or frequency of smoking. In some embodiments, the PDE5 inhibitor is sildenafil (e.g., Viagra).
    Type: Application
    Filed: November 13, 2020
    Publication date: February 9, 2023
    Applicants: BEHAVIORAL DIAGNOSTICS, LLC, UNIVERSITY OF IOWA RESEARCH FOUNDATION
    Inventors: Eric A. HOFFMAN, Albert Tao-man LEUNG, Alejandro Comellas, Alicia GERKE, Robert PHILIBERT
  • Compositions and methods for detecting predisposition to a substance use disorder
    Patent number: 9994904
    Abstract: The present invention provides screening kits, compositions, and diagnostic methods for determining whether a subject has a predisposition to, or likelihood of having, a substance use disorder by determining a nucleic acid methylation profile from a biological sample from the subject, wherein a given profile indicates that the subject has a predisposition to a substance use disorder.
    Type: Grant
    Filed: February 1, 2016
    Date of Patent: June 12, 2018
    Assignee: Behavioral Diagnostics, LLC
    Inventors: Robert Philibert, Anup Madan